Jun 1998 | Public Health Rep. 113(Suppl 1):160-169
This analysis describes the Outreach-Assisted Model of Partner Notification, an innovative strategy for encouraging seropositive injecting drug users ...
Jun 1998 | Public Health Rep. 113(Suppl 1):97-106
As the acquired immunodeficiency syndrome (AIDS) epidemic among drug users enters its third decade in the United States, it is important to consider t...
Jun 1998 | Public Health Rep. 113(Suppl 1):67-74
This chapter attempts to describe the factors influencing the transmission of syringe-born viruses, to review the effects of syringe exchange programs...
Jun 1998 | Public Health Rep. 113(Suppl 1):1-3
No Description
Jun 1998 | Public Health Rep. 113(Suppl 1):42-57
Since 1985, community outreach efforts to combat acquired immunodeficiency syndrome (AIDS) among injecting drug users (IDUs) in the United States have...
Jun 1998 | Public Health Rep. 113(Suppl 1):194-204
After more than 10 years of experience conducting behavioral changes interventions and with accumulated research results, several emergent principle h...
Jun 1998 | Public Health Rep. 113(Suppl 1):75-80
Injecting drug users (IDUs) are at high risk for infection by human immunodeficiency virus (HIV) and other blood-borne pathogens. In the United States...
Jun 1998 | Public Health Rep. 113(Suppl 1):182-188
Acquired immunodeficiency syndrome (AIDS) was formally identified among injecting drug users (IDUs) in 1981, and research on preventing human immunode...
Jun 1998 | Public Health Rep. 113(Suppl 1):116-128
High risk injection practices are common among injecting drug users (IDUs), even following intervention efforts. Moreover, relapse to risk behaviors h...
Jun 1998 | Public Health Rep. 113(Suppl 1):129-139
Although lowering incidence rates of human immunodeficiency virus (HIV) transmission is the primary goal of needle exchange programs (NEPs), other des...
Jun 1998 | Public Health Rep. 113(Suppl 1):107-115
We undertook a study of the role of methadone maintenance in protecting injecting drug users (IDUs) from human immunodeficiency virus (HIV) infection ...
Jun 1998 | Public Health Rep. 113(Suppl 1):140-150
To review human immunodeficiency virus (HIV) risk reduction interventions among injecting drug users (IDUs) that have adopted a network approach.|The ...
Jun 1998 | Public Health Rep. 113(Suppl 1):170-181
Human immunodeficiency virus (HIV) infection associated with injecting drug use has been reported in at least 98 countries and territories worldwide. ...
Jun 1998 | Public Health Rep. 113(Suppl 1):90-96
Our first objective was to develop an index of satellite exchange and then determine whether satellite exchangers (SEs) differed demographically or be...
Jun 1998 | Public Health Rep. 113(Suppl 1):151-159
Guided by a social influence and empowerment framework, peer leaders in the injecting drug user (IDU) community were trained to promote human immunode...
Jun 1998 | Public Health Rep. 113(Suppl 1):4-18
No Description
6-1998 | Public Health Rep. 113(Suppl 1)
HIV prevention with drug-using populations : current status and future prospects
6-1998 | Public Health Rep. 113(Suppl 1)
The National Institute on Drug Abuse (NIDA), in collaboration with the Office of AIDS Research of the National Institutes of Health, invited national ...
06/01/1998 | Public Health Rep. 113(Suppl 1):81-89
To break the link between drug use and the human immunodeficiency virus (HIV), in 1992 the state of Connecticut rescinded a 14-year ban on pharmacy sa...
06/01/1998 | Public Health Rep. 113(Suppl 1):31-41
The purpose of this chapter is to describe the results of a randomized study (funded by the National Institute on Drug Abuse [NIDA]) comparing a peer-...
|
[PDF-780.81 KB]